128 related articles for article (PubMed ID: 31400761)
1. Trans-acting non-synonymous variant of FOXA1 predisposes to hepatocellular carcinoma through modulating FOXA1-ERα transcriptional program and may have undergone natural selection.
Wang S; Xiang C; Mou L; Yang Y; Zhong R; Wang L; Sun C; Qin Z; Yang J; Qian J; Zhao Y; Wang Y; Pan X; Qie J; Jiang Y; Wang X; Yang Y; Zhou WP; Miao X; He F; Jin L; Wang H
Carcinogenesis; 2020 Apr; 41(2):146-158. PubMed ID: 31400761
[TBL] [Abstract][Full Text] [Related]
2. Integrative genomic analysis identifies that SERPINA6-rs1998056 regulated by FOXA/ERα is associated with female hepatocellular carcinoma.
Shen N; Gong J; Wang Y; Tian J; Qian J; Zou L; Chen W; Zhu B; Lu X; Zhong R; Guo A; Wang L; Miao X
PLoS One; 2014; 9(9):e107246. PubMed ID: 25198130
[TBL] [Abstract][Full Text] [Related]
3. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
4. FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients.
He S; Zhang J; Zhang W; Chen F; Luo R
J Exp Clin Cancer Res; 2017 Dec; 36(1):175. PubMed ID: 29208003
[TBL] [Abstract][Full Text] [Related]
5. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
6. Nonreceptor protein tyrosine phosphatases (NRPTPs) gene family associates with the risk of hepatocellular carcinoma in a Chinese hepatitis B virus-related subjects.
Shen N; Wang P; Li Y; Zhu Y; Gong Y; Zhong R; Lu Y; Cheng L
Mol Carcinog; 2020 Aug; 59(8):980-988. PubMed ID: 32484301
[TBL] [Abstract][Full Text] [Related]
7. Association between polymorphisms of the
He XT; Xu HQ; Wang XM; He XS; Niu JQ; Gao PJ
World J Gastroenterol; 2017 Jan; 23(2):232-241. PubMed ID: 28127197
[TBL] [Abstract][Full Text] [Related]
8. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
[TBL] [Abstract][Full Text] [Related]
9. The influence of caveolin-1 gene polymorphisms on hepatitis B virus-related hepatocellular carcinoma susceptibility in Chinese Han population: A case-control study.
Zhang J; Xue F; Chen S; Zhang D; Lu C; Tang G
Medicine (Baltimore); 2017 Oct; 96(42):e7359. PubMed ID: 29049173
[TBL] [Abstract][Full Text] [Related]
10. Association of single nucleotide polymorphisms in VDR and DBP genes with HBV-related hepatocellular carcinoma risk in a Chinese population.
Peng Q; Yang S; Lao X; Li R; Chen Z; Wang J; Qin X; Li S
PLoS One; 2014; 9(12):e116026. PubMed ID: 25541958
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.
Zhai Y; Zhou G; Deng G; Xie W; Dong X; Zhang X; Yu L; Yang H; Yuan X; Zhang H; Zhi L; Yao Z; Shen Y; Qiang B; He F
Gastroenterology; 2006 Jun; 130(7):2001-9. PubMed ID: 16762623
[TBL] [Abstract][Full Text] [Related]
12. [MicroRNA-30a inhibits proliferation of hepatocellular carcinoma cells via targeted regulation of forkhead-box protein A1].
Li Y; Fu L; Fu XY; Li RH; Peng SF
Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):706-711. PubMed ID: 29108194
[No Abstract] [Full Text] [Related]
13. A Non-Synonymous Single Nucleotide Polymorphism in the HJURP Gene Associated with Susceptibility to Hepatocellular Carcinoma among Chinese.
Huang W; Zhang H; Hao Y; Xu X; Zhai Y; Wang S; Li Y; Ma F; Li Y; Wang Z; Zhang Y; Zhang X; Liang R; Wei Z; Cui Y; Li Y; Yu X; Ji H; He F; Xie W; Zhou G
PLoS One; 2016; 11(2):e0148618. PubMed ID: 26863619
[TBL] [Abstract][Full Text] [Related]
14. Association of the GLB1 rs4678680 genetic variant with risk of HBV-related hepatocellular carcinoma.
Wang WT; Li Z; Shi M; Zhu H; Xiong X; Shang J; Liu J; Teng M; Yang M
Oncotarget; 2016 Aug; 7(35):56501-56507. PubMed ID: 27489354
[TBL] [Abstract][Full Text] [Related]
15. A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets.
Wijetunga NA; Pascual M; Tozour J; Delahaye F; Alani M; Adeyeye M; Wolkoff AW; Verma A; Greally JM
Oncogene; 2017 Apr; 36(14):2030-2044. PubMed ID: 27721404
[TBL] [Abstract][Full Text] [Related]
16. Association of CD44 polymorphisms and susceptibility to HBV-related hepatocellular carcinoma in the Chinese population.
Deng Y; Chen ZJ; Lan F; He QT; Chen SY; Du YF; Li S; Qin X
J Clin Lab Anal; 2019 Oct; 33(8):e22977. PubMed ID: 31301090
[TBL] [Abstract][Full Text] [Related]
17. TNFalpha promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population.
Jung KW; Ha E; Yu GI; Kim SJ; Chung WJ; Jang BK; Lee JJ; Shin DH; Hwang JS
Clin Chim Acta; 2009 Sep; 407(1-2):16-9. PubMed ID: 19545551
[TBL] [Abstract][Full Text] [Related]
18. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
[TBL] [Abstract][Full Text] [Related]
19. PNPLA3 rs738409 is not associated with the risk of hepatocellular carcinoma and persistent infection of hepatitis B virus (HBV) in HBV-related subjects: A case-control study and meta-analysis on Asians.
Wang P; Wu C; Li Y; Gong Y; Shen N
Gene; 2020 Jun; 742():144585. PubMed ID: 32173542
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
Yamaguchi N; Nakayama Y; Yamaguchi N
J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
